Regeneron Pharma (REGN) shares up after Jim Cramer called it a good stock

robot
Abstract generation in progress

Shares of Regeneron Pharmaceuticals (REGN) saw an increase after financial commentator Jim Cramer publicly endorsed the stock. Cramer’s positive remarks included calling Regeneron a good stock for investment. This surge highlights the potential impact of high-profile financial endorsements on stock performance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin